Natera EBITDA 2014-2024 | NTRA
Natera annual and quarterly EBITDA history from 2014 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Natera EBITDA for the quarter ending September 30, 2024 was $-0.031B, a 70.07% decline year-over-year.
- Natera EBITDA for the twelve months ending September 30, 2024 was $-0.212B, a 55.64% decline year-over-year.
- Natera 2023 annual EBITDA was $-0.42B, a 19% decline from 2022.
- Natera 2022 annual EBITDA was $-0.518B, a 15.71% increase from 2021.
- Natera 2021 annual EBITDA was $-0.448B, a 121.99% increase from 2020.
| Natera Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-420 |
| 2022 | $-518 |
| 2021 | $-448 |
| 2020 | $-202 |
| 2019 | $-107 |
| 2018 | $-106 |
| 2017 | $-127 |
| 2016 | $-93 |
| 2015 | $-54 |
| 2014 | $6 |
| 2013 | $-23 |
| Natera Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-31 |
| 2024-06-30 | $-36 |
| 2024-03-31 | $-67 |
| 2023-12-31 | $-78 |
| 2023-09-30 | $-103 |
| 2023-06-30 | $-106 |
| 2023-03-31 | $-132 |
| 2022-12-31 | $-137 |
| 2022-09-30 | $-113 |
| 2022-06-30 | $-137 |
| 2022-03-31 | $-132 |
| 2021-12-31 | $-134 |
| 2021-09-30 | $-145 |
| 2021-06-30 | $-111 |
| 2021-03-31 | $-58 |
| 2020-12-31 | $-69 |
| 2020-09-30 | $-54 |
| 2020-06-30 | $-46 |
| 2020-03-31 | $-32 |
| 2019-12-31 | $-32 |
| 2019-09-30 | $-19 |
| 2019-06-30 | $-26 |
| 2019-03-31 | $-30 |
| 2018-12-31 | $-28 |
| 2018-09-30 | $-25 |
| 2018-06-30 | $-25 |
| 2018-03-31 | $-28 |
| 2017-12-31 | $-45 |
| 2017-09-30 | $-24 |
| 2017-06-30 | $-26 |
| 2017-03-31 | $-33 |
| 2016-12-31 | $-40 |
| 2016-09-30 | $-25 |
| 2016-06-30 | $-21 |
| 2016-03-31 | $-8 |
| 2015-12-31 | $-16 |
| 2015-09-30 | $-19 |
| 2015-06-30 | $-14 |
| 2015-03-31 | $-5 |
| 2014-12-31 | |
| 2014-09-30 | $6 |
| 2014-06-30 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.209B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $92.839B | 12.14 |
| Cencora (COR) | United States | $49.468B | 18.60 |
| DiDi Global (DIDIY) | China | $22.650B | 0.00 |
| ICON (ICLR) | Ireland | $16.344B | 14.56 |
| Revvity (RVTY) | United States | $15.033B | 26.11 |
| Avantor (AVTR) | United States | $14.626B | 21.93 |
| BioMerieux (BMXMF) | France | $14.203B | 0.00 |
| Viatris (VTRS) | United States | $13.523B | 4.17 |
| CochLear (CHEOY) | Australia | $12.916B | 0.00 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Doximity (DOCS) | United States | $10.767B | 63.37 |
| Medpace Holdings (MEDP) | United States | $10.662B | 30.04 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.135B | 0.00 |
| HealthEquity (HQY) | United States | $9.429B | 47.30 |
| Sonic Healthcare (SKHHY) | Australia | $8.657B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.266B | 15.97 |
| Bausch + Lomb (BLCO) | Canada | $6.301B | 29.31 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| BrightSpring Health Services (BTSG) | United States | $4.136B | 87.96 |
| Organon (OGN) | United States | $4.079B | 4.11 |
| Sotera Health (SHC) | United States | $3.875B | 20.73 |
| Surgery Partners (SGRY) | United States | $3.273B | 37.32 |
| Concentras Parent (CON) | United States | $2.998B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.937B | 0.00 |
| Premier (PINC) | United States | $2.191B | 11.40 |
| Ardent Health Partners (ARDT) | United States | $2.098B | 0.00 |
| PACS (PACS) | United States | $2.080B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.079B | 0.00 |
| Progyny (PGNY) | United States | $1.980B | 40.09 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Teladoc Health (TDOC) | United States | $1.782B | 0.00 |
| Agilon Health (AGL) | United States | $1.413B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.219B | 11.92 |
| CareDx (CDNA) | United States | $1.210B | 0.00 |
| Embecta (EMBC) | United States | $1.070B | 7.48 |
| AMN Healthcare Services Inc (AMN) | United States | $1.036B | 7.02 |
| Establishment Labs Holdings (ESTA) | $0.947B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.637B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| DocGo (DCGO) | United States | $0.490B | 18.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.480B | 12.56 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| Enhabit (EHAB) | United States | $0.422B | 36.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.280B | 0.00 |
| MultiPlan (MPLN) | United States | $0.267B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Nutex Health (NUTX) | United States | $0.243B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
| Biodesix (BDSX) | United States | $0.151B | 0.00 |
| So-Young (SY) | China | $0.105B | 17.83 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| ModivCare (MODV) | United States | $0.066B | 3.57 |
| Oncology Institute (TOI) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OncoCyte (OCX) | United States | $0.034B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |